Cargando…

Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study

The recipient muscle status is closely associated with postoperative poor survival in recipients of living donor liver transplantation (LDLT). However, it is uncertain whether LDLT donor muscle quality and quantity affect graft quality. Hence, we analyzed the correlation between donor muscle status...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomiyama, Takahiro, Harada, Noboru, Toshima, Takeo, Nakayama, Yuki, Toshida, Katsuya, Morinaga, Akinari, Kosai-Fujimoto, Yukiko, Tomino, Takahiro, Kurihara, Takeshi, Takeishi, Kazuki, Nagao, Yoshihiro, Morita, Kazutoyo, Itoh, Shinji, Yoshizumi, Tomoharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Health Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784912/ https://www.ncbi.nlm.nih.gov/pubmed/36568139 http://dx.doi.org/10.3389/ti.2022.10723

Ejemplares similares

Caution for living donor liver transplantation with congenital portosystemic shunt: a case report
por: Nagao, Yoshihiro, et al.
Publicado: (2022)

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
por: Toshida, Katsuya, et al.
Publicado: (2022)

Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2022)

Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma
por: Toshida, Katsuya, et al.
Publicado: (2022)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Clinical effects of the use of the indocyanine green fluorescence imaging technique in laparoscopic partial liver resection
por: Itoh, Shinji, et al.
Publicado: (2022)

Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report
por: Tomiyama, Takahiro, et al.
Publicado: (2021)

Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
por: Yonemura, Yusuke, et al.
Publicado: (2020)

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2022)

Association between Sarcopenia and Omega-3 Polyunsaturated Fatty Acid in Patients with Hepatocellular Carcinoma
por: Itoh, Shinji, et al.
Publicado: (2022)

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature
por: Iseda, Norifumi, et al.
Publicado: (2018)

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients
por: Tomiyama, Takahiro, et al.
Publicado: (2023)

Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Which is better to use “body weight” or “standard liver weight”, for predicting small‐for‐size graft syndrome after living donor liver transplantation?
por: Toshima, Takeo, et al.
Publicado: (2020)

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2021)

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
por: Yugawa, Kyohei, et al.
Publicado: (2020)

The authors’ reply: Indispensable discrepancy between predicted graft “volume” and actual graft “weight” in clinical practice in living‐donor liver transplantation
por: Toshima, Takeo, et al.
Publicado: (2021)

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2020)

Curative surgery for multiple hepatocellular carcinomas after lenvatinib plus transarterial chemoembolization: a case report
por: Shiraishi, Jin, et al.
Publicado: (2023)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
por: Iseda, Norifumi, et al.
Publicado: (2021)

Multiple liver metastases originating from synchronous double cancer of neuroendocrine tumor and rectal cancer: a case report
por: Omori, Sachie, et al.
Publicado: (2020)

Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation
por: Elshawy, Mohamed, et al.
Publicado: (2020)

Correction to: Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation
por: Elshawy, Mohamed, et al.
Publicado: (2020)

Cystic Liver Infection after Living Donor Liver Transplantation: A Case Report
por: Kudou, Kensuke, et al.
Publicado: (2014)

Evaluation of Expanded Criteria Donors Using the Kidney Donor Profile Index and the Preimplantation Renal Biopsy
por: Villanego, F., et al.
Publicado: (2022)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

The Suitability of Potential Organ Donors Using Real Case-Scenarios; Do we Need to Create a “Donor Board” Process for Donors Perceived as Unlikely Suitable?
por: Marsolais, Pierre, et al.
Publicado: (2022)

An Inventory of Deceased Donor Family Care and Contact Between Donor Families and Recipients in 15 European Countries
por: Wind, Tineke, et al.
Publicado: (2022)

Relinquishing Anonymity in Living Donor Kidney Transplantation: Lessons Learned From the UK Policy for Anonymous Donors
por: Pronk, Mathilde C., et al.
Publicado: (2022)

Estimation of Donor Renal Function After Living Donor Nephrectomy: The Value of the Toulouse-Rangueil Predictive Model
por: Prudhomme, Thomas, et al.
Publicado: (2023)

Corrigendum: An Inventory of Deceased Donor Family Care and Contact Between Donor Families and Recipients in 15 European Countries
por: Wind, Tineke, et al.
Publicado: (2022)

External Validation of the Toulouse-Rangueil Predictive Model to Estimate Donor Renal Function After Living Donor Nephrectomy
por: Almeida, Manuela, et al.
Publicado: (2023)

Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report
por: Kurihara, Takeshi, et al.
Publicado: (2016)

Utilization of the Pancreas From Donors With an Extremely High Pancreas Donor Risk Index: Report of the National Registry of Pancreas Transplantation
por: Kaku, Keizo, et al.
Publicado: (2023)

A Multi-Facility, Randomized, Comparative Study Examining the Efficacy of Biliary Reconstruction Under a Surgical Microscope in Living Donor Liver Transplantation
por: Soyama, Akihiko, et al.
Publicado: (2021)

Deceased Donor Characteristics and Kidney Transplant Outcomes
por: Sharif, Adnan
Publicado: (2022)

Considering ABO Incompatible Living Donor Kidney Transplantation Before Deceased Donor Kidney Transplantation in Children: A Letter to the Editor
por: Paessler, Alicia, et al.
Publicado: (2023)

Usefulness of microsurgical back‐table angioplasty for multiple hepatic arteries in living donor liver transplantation
por: Harada, Noboru, et al.
Publicado: (2020)

Matching Donor and Recipient Size in Pediatric Heart Transplantation
por: Singh, Tajinder P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ulcr9r1r56n1oqp5icdku8h3hm